Maxime Dely: How Artificial Intelligence Will Revolutionize Transfusion Safety
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared on LinkedIn:
”From bag to patient: How artificial intelligence will revolutionize transfusion safety
Artificial intelligence won’t save lives on its own — not yet. But soon, it will learn to, quietly, behind the scenes of hospitals. And in the world of blood transfusion, its impact will be profound.
Every second, blood bags will continue to save lives.
But behind each transfusion will remain a complex equation: compatibility, urgency, availability, traceability… and the persistent risk of human error.
What if AI became our greatest ally in making all this safer?
In the coming years, AI will enter the transfusion chain:
- Predictive analysis of needs to prevent shortages
- Automated detection of anomalies in biological data
- Intelligent matching to minimize rare incompatibilities
Where technicians once relied solely on experience and intuition,
AI will step in — not to replace, but to reinforce human vigilance.
Soon, blood bank organizations and hospitals will deploy models capable of:
- Anticipating peaks in blood demand
- Predicting high-risk transfusions before they occur
But beyond technology, a deeper question will emerge — one of trust and ethics:
How will algorithms and human judgment coexist in a field where every drop counts?
So, what do you think — will AI become a cornerstone of transfusion safety, or remain just a supporting tool?”

Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring